FTC requests information on Optum’s $4.9B purchase of DaVita

The Federal Trade Commission sent DaVita a letter seeking more information on its $4.9 billion sale to UnitedHealth subsidiary Optum, according to a DaVita SEC filing.

Advertisement

The letter, received March 12, asks DaVita to provide additional information and documents to gain regulatory approval for the acquisition, which was announced in December 2017. If the transaction obtains FTC approval, DaVita will join Optum’s OptumCare division. 

DaVita expects the transaction to close in 2018.

More articles on transactions/valuation:
Cognizant agrees to acquire Bolder Healthcare Solutions — 4 highlights
Nobilis looking for more large in-network acquisitions in 2018: 5 key quotes from CEO Harry Fleming
RWJBarnabas to open 7 outpatient offices, building on ambulatory care expansion — 4 notes

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.